Rationale and design of the EVOLVE Short DAPT Study to assess 3‐month dual antiplatelet therapy in subjects at high risk for bleeding undergoing percutaneous coronary intervention
暂无分享,去创建一个
M. Price | H. Dauerman | A. Kirtane | S. Windecker | L. Mauri | R. Yeh | I. Meredith | D. Kereiakes | T. Christen | D. Allocco